Pulmonary edema epidemiology and demographics

Jump to navigation Jump to search

Pulmonary edema Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pulmonary Edema from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

Electrocardiography

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventional Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pulmonary edema epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pulmonary edema epidemiology and demographics

CDC on Pulmonary edema epidemiology and demographics

Pulmonary edema epidemiology and demographics in the news

Blogs on Pulmonary edema epidemiology and demographics

Directions to Hospitals Treating Pulmonary edema

Risk calculators and risk factors for Pulmonary edema epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Farnaz Khalighinejad, MD [2]

Overview

The prevalence of pulmonary edema was estimated to be 75000-83000 cases per 100,000 individuals among heart failure patients with reduced ejection fraction. Pulmonary edema commonly affects individuals older than 65 years of age. Males are more commonly affected by pulmonary edema than woman.

Epidemiology and Demographics

Incidence

  • The incidence of neurogenic pulmonary edema is approximately 2000 to 42900 per 100,000 individuals in patients with subarachnoid hemorrhage.[1][2]
  • The incidence of neurogenic pulmonary edema is approximately 20000 per 100,000 individuals in patients with traumatic brain injury.[3]

Prevalence

  • The prevalence of pulmonary edema was estimated to be 75000-83000 cases per 100,000 individuals among heart failure patients with reduced ejection fraction.[4]

Mortality rate

  • The mortality rate of pulmonary edema is approximately 12000 per 100000 among in-hospital patients.[5]
  • The median time from the pulmonary edema until death is approximately 10 days.
  • Higher in-hospital mortality rate are associated with left ventricular myocardial function.

Age

  • Pulmonary edema commonly affects individuals older than 65 years of age.[5]

Race

  • Blacks have the highest risk for heart failure as underlying cause of pulmonary edema.[6]

Gender

  • Males are more commonly affected by pulmonary edema than woman.[5]


References

  1. Fontes RB, Aguiar PH, Zanetti MV, Andrade F, Mandel M, Teixeira MJ (April 2003). "Acute neurogenic pulmonary edema: case reports and literature review". J Neurosurg Anesthesiol. 15 (2): 144–50. PMID 12658001.
  2. Solenski NJ, Haley EC, Kassell NF, Kongable G, Germanson T, Truskowski L, Torner JC (June 1995). "Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Participants of the Multicenter Cooperative Aneurysm Study". Crit. Care Med. 23 (6): 1007–17. PMID 7774210.
  3. Bratton SL, Davis RL (April 1997). "Acute lung injury in isolated traumatic brain injury". Neurosurgery. 40 (4): 707–12, discussion 712. PMID 9092843.
  4. Platz E, Jhund PS, Campbell RT, McMurray JJ (September 2015). "Assessment and prevalence of pulmonary oedema in contemporary acute heart failure trials: a systematic review". Eur. J. Heart Fail. 17 (9): 906–16. doi:10.1002/ejhf.321. PMC 4725064. PMID 26230356.
  5. 5.0 5.1 5.2 Edoute Y, Roguin A, Behar D, Reisner SA (February 2000). "Prospective evaluation of pulmonary edema". Crit. Care Med. 28 (2): 330–5. PMID 10708162.
  6. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL (October 2013). "2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines". J. Am. Coll. Cardiol. 62 (16): e147–239. doi:10.1016/j.jacc.2013.05.019. PMID 23747642.


Template:WikiDoc Sources